Global qPCR and dPCR Instrumentation Market Growth 2019-2024

Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.

Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digitalâ„¢ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.

Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
On the basis of technology, the dPCR and qPCR market is categorized into digital PCR (dPCR) and quantitative PCR (qPCR/real-time PCR). The qPCR technology segment is expected to account for the larger share of the global dPCR and qPCR market in 2017; whereas, the dPCR segment is expected to grow at the highest CAGR during the forecast period. Factors such as ongoing technological developments in dPCR, continued expansion in distribution networks of emerging dPCR product manufacturers in global markets, and growing private funding to develop and commercialize innovative dPCR instruments are contributing to the growth of the dPCR technology segment.
On the basis of application, the dPCR and qPCR market is categorized into clinical applications, research applications, and others. The clinical applications segment is further divided into pathogen testing, oncology testing, blood screening, and other clinical applications. The clinical applications segment is expected to grow at the highest CAGR during the forecast period owing to the technological benefits offered by dPCR over qPCR and traditional PCR, growing adoption of dPCR among hospitals and diagnostic centers, increasing global burden for infectious diseases and cancer, and expansion in distribution networks of emerging dPCR product manufacturers.
Geographically, North America holds the largest market share, with about 48.68% production share and 40.77% consumption market share in 2017, followed by Europe. The strong position of North America in this market can be attributed to factors such as increase in public and private funding and growing number of research grants to support gene-based research (such as qPCR and dPCR). Asia-Pacific is projected to be the fastest-growing region in the qPCR and dPCR market owing to increasing focus of global life sciences market players on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies. Due to the significant growth opportunities offered by emerging countries, a number of players operating in the market are focusing on expanding their product distribution networks across emerging countries.

According to this study, over the next five years the qPCR and dPCR Instrumentation market will register a 8.2% CAGR in terms of revenue, the global market size will reach US$ 1480 million by 2024, from US$ 930 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in qPCR and dPCR Instrumentation business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of qPCR and dPCR Instrumentation market by product type, application, key manufacturers and key regions and countries.

This study considers the qPCR and dPCR Instrumentation value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
dPCR
qPCR
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Clinical Use
Research Use
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Roche
QIAGEN
Bio-rad
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
Fluidigm
RainDance Technologies

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global qPCR and dPCR Instrumentation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of qPCR and dPCR Instrumentation market by identifying its various subsegments.
Focuses on the key global qPCR and dPCR Instrumentation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the qPCR and dPCR Instrumentation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of qPCR and dPCR Instrumentation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Choose License Type



24/7 Service

Experience round the clock customer support and impeccable services from Pioneer Reports. Our domain experts are available 24/7 to solve your problems directly.

Quality & Accuracy

We know the importance of Quality & Accuracy factor for any business giant. Our tied up prominent publishers ensures quality, accuracy and reliability Standardized systems and processes involved in every phase of a study

Customer Satisfaction

Customer satisfaction is our highest priority. We strive to be the best in our field to ensure our customers get a professional service at all times. Pioneer Reports caters global network services to enterprises ranging from small and medium sized to Fortune 500.